Product NDC: | 21695-734 |
Proprietary Name: | Lisinopril and hydrochlorothiazide |
Non Proprietary Name: | Lisinopril and hydrochlorothiazide |
Active Ingredient(s): | 12.5; 20 mg/1; mg/1 & nbsp; Lisinopril and hydrochlorothiazide |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 21695-734 |
Labeler Name: | Rebel Distributors Corp |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076194 |
Marketing Category: | ANDA |
Start Marketing Date: | 20030301 |
Package NDC: | 21695-734-30 |
Package Description: | 30 TABLET in 1 BOTTLE, PLASTIC (21695-734-30) |
NDC Code | 21695-734-30 |
Proprietary Name | Lisinopril and hydrochlorothiazide |
Package Description | 30 TABLET in 1 BOTTLE, PLASTIC (21695-734-30) |
Product NDC | 21695-734 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Lisinopril and hydrochlorothiazide |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20030301 |
Marketing Category Name | ANDA |
Labeler Name | Rebel Distributors Corp |
Substance Name | HYDROCHLOROTHIAZIDE; LISINOPRIL |
Strength Number | 12.5; 20 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |